Semaglutide for Diabetic Kidney Disease
This trial looks at whether semaglutide, a diabetes medication, can help people with diabetes and kidney disease who are overweight or obese.
- Diabetic Kidney Disease
- Chronic Kidney Disease
- Type 2 Diabetes Mellitus in Obesity
- Severe Obesity
1 Primary · 7 Secondary · Reporting Duration: Baseline to 9 months
2 Treatment Groups
1 of 2
1 of 2
15 Total Participants · 2 Treatment Groups
Primary Treatment: Semaglutide · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
|Geisinger Medical Center||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||50.0%|
Frequently Asked Questions
Are there any Semaglutide-related fatalities on record?
"Semaglutide was given a score of 3 by our team at Power. This is due to this medication being in Phase 3 trials, which indicates that there is not just some evidence of efficacy, but multiple rounds of data supporting safety as well." - Anonymous Online Contributor
What medical conditions respond well to Semaglutide?
"Semaglutide is frequently used to help patients manage their weight over the long term. Additionally, it can be employed as part of a treatment plan that includes a calorie-restricted diet, physical activity, and treating at least one other condition that is related to obesity." - Anonymous Online Contributor
Are there any open slots for volunteers in this clinical trial?
"Correct, the information available on clinicaltrials.gov indicates that this study is actively looking for participants. The listing was created on 7/23/2021 and edited on 2/3/2022. They are hoping to recruit 150 patients from 2 locations." - Anonymous Online Contributor
What other drugs has Semaglutide been tested against in a clinical setting?
"At the moment, 59 clinical trials concerning Semaglutide are active with 27 of them being Phase 3 research. Even though a few of the investigations for Semaglutide are happening near Loma Linda, 3899 other locations are conducting studies regarding Semaglutide." - Anonymous Online Contributor
How many people are being included in this research project?
"Yes, as of February 3rd, 2022 this clinical trial is still seeking 150 participants from two different sites, as noted on clinicaltrials.gov" - Anonymous Online Contributor
What are the unique aspects of this clinical trial?
"There are 59 ongoing clinical trials for Semaglutide in 766 cities and 55 nations. The first study was completed in 2018 by Novo Nordisk A/S. It reached Phase 4 approval after involving 1387 patients. In the two years since, 123 more trials have finished." - Anonymous Online Contributor